RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background/Aims
The Lyon Consensus defined parameters based on upper endoscopy and 24-hour combined multichannel intraluminal impedancepH (MII-pH), that conclusively establish the presence of gastroesophageal reflux disease (GERD). However, the true role of upper endoscopy and MII-pH to evaluate patients with extraesophageal symptoms (EES) has not been well established. Hypopharyngeal MII (HMII), which directly measures laryngopharyngeal reflux (LPR) events, has been utilized to evaluate patients with EES suggestive of LPR.
Methods
This was a retrospective study involving patients with EES for > 12 weeks despite proton pump inhibitor therapy, and had no endoscopic confirmatory evidence for GERD and negative MII-pH. All patients were subsequently referred for further evaluation of EES with “unknown” etiology and underwent laryngoscopy and HMII. Based on HMII, abnormal proximal exposure (APE) was defined as LPR ≥ 1/day and/or full column reflux (reflux 2 cm distal to the upper esophageal sphincter) > 4/day. Patients with APE were offered antireflux surgery (ARS) and the outcome of ARS was objectively assessed using Reflux Symptom Index.
Results
Of 21 patients with EES which was thought to be GERD-unrelated based on endoscopy and MII-pH, 17 patients (81%) had APE. Eight patients with APE who had undergone ARS had significant symptomatic improvement in the Reflux Symptom Index score (19.6 ± 4.9 pre-ARS to 5.8 ± 1.4 post-ARS, P = 0.008).
Conclusions
A conventional diagnostic approach using endoscopy and MII-pH may not be sufficient to evaluate patients with EES suggestive of LPR. HMII is essential to evaluate patients with EES, and APE could be a reliable indicator for successful treatment outcomes.
(J Neurogastroenterol Motil 2022;28:69-77)

참고문헌 (Reference)

1 Belafsky PC, "Validity and reliability of the reflux symptom index(RSI)" 16 : 274-277, 2002

2 Malhotra A, "Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease" 42 : 271-278, 2008

3 Weusten BL, "The symptom-association probability : an improved method for symptom analysis of 24-hour esophageal pH data" 107 : 1741-1745, 1994

4 Hicks DM, "The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers" 16 : 564-579, 2002

5 Koufman JA, "The otolaryngologic manifestations of gastroesophageal reflux disease(GERD) : a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury" 101 (101): 1-78, 1991

6 Vakil N, "The Montreal definition and classification of gastroesophageal reflux disease : a global evidence-based consensus" 101 : 1900-1920, 2006

7 Matteo Ghisa ; Brigida Barberio ; Vincenzo Savarino ; Elisa Marabotto ; Mentore Ribolsi ; Giorgia Bodini ; Fabiana Zingone ; Marzio Frazzoni ; Edoardo Savarino, "The Lyon Consensus: Does It Differ From the Previous Ones?" 대한소화기 기능성질환∙운동학회 26 (26): 311-321, 2020

8 DiBaise JK, "The LA classification for esophagitis : a call for standardization" 94 : 3403-3404, 1999

9 Komatsu Y, "Proximal reflux as a cause of adult-onset asthma : the case for hypopharyngeal impedance testing to improve the sensitivity of diagnosis" 148 : 50-58, 2013

10 Carroll TL, "Nissen fundoplication for laryngopharyngeal reflux after patient selection using dual pH, full column impedance testing : a pilot study" 125 : 722-728, 2016